In Vitro Characterization of Nasal Spray to Asses Bioequivalence
DOI:
https://doi.org/10.22270/ajprd.v9i6.1050Keywords:
SAC, Priming and repriming, Spray pattern, plume geometry, Droplet size distribution and Drug in small particles.Abstract
To layout the characterization of Nasal sprays and discuss the characterization method and sampling plan to assess the in -vitro bioequivalence of test product and reference product. The in -vitro bioequivalence study of nasal sprays are useful to understand the efficiency of test product in comparison to innovator so that the equivalency in the in -vivo studies can be assessed.
The in -vitro bio equivalency characterization of nasal sprays helps us to correlate the efficiency of test product with respect to the reference product, so that the efficacy and safety can be achieved in par with Reference listed drug.
The characterization studies include the product behavior throughout the unit life cycle. The nasal spray test includes the SAC, Priming, repriming, Spray pattern, plume geometry, Droplet size distribution and Drug in small particles.
Downloads
References
2. https://www.ondrugdelivery.com/bioequivalence-nasal-sprays-importance-device-performance
3. Dayal P, Shaik MS, Singh M. Evaluation of different parameters that affect of droplet size distribution from nasal spray using the Malvern spray tec. Journal of pharma science 2014;93(7):1725-42
4. Vitthal Kulkarni and Charles shaw, Formulation characterization of nasal sprays. inhalation June 2012:10-5
5. Suman j. In-Vitro nasal spray characterization. inhalation 2009:15-19
6. FDA- Contains Nonbinding Recommendations Draft Guidance on Mometasone Furoate Monohydrate Recommended Sep 2015, Revised Feb 2019, jun 2020 Contains.
7. FDA - Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products--Chemistry, Manufacturing, and Controls Documentation-US FDA guidance document- July 2002.
8. FDA- Product specific guidance contains Nonbinding recommendation Draft guidance on fluticasone propionate, Recommended Sept 2015; Revised Feb 2019
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.